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ABSTRACT:DeletionofPhe508(ΔF508)inthefirstnucleotide-bindingdomain(NBD1)ofCFTRcausescystic
fibrosis. The mutation severely reduces the stability and folding of the protein by disrupting interactions
between NBD1 and the second transmembrane domain (TMD2). We found that replacement of Val510 with
acidicresidues(butnotneutralorpositiveresidues)promotedmaturationofΔF508-CFTRwithV510Dmore
efficiently than V510E. Promotion of ΔF508-CFTR maturation did not require NBD2 as introduction of
V510D into a ΔNBD2/ΔF508-CFTR mutant restored maturation to levels similar to that of full-length
protein. The V510D mutation increased the half-life of mature ΔF508-CFTR at the cell surface by about
5-fold to resemble the half-life of wild-type CFTR. It was also observed that introduction of the V510R/
R1070DmutationsintoΔF508-CFTRalsopromotedmaturationwhereastheV510D/R1070Amutationsdid
not. We propose that the V510D mutation in NBD1 promotes maturation and stabilizes ΔF508-CFTR at the
cell surface through formation of a salt bridge with Arg1070 in TMD2.
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a cAMP-regulated chloride channel that is located
on the apical surface of epithelial cells that line lung airways
and ducts of various glands (reviewed in ref 1). Its physiological
role is to maintain salt and water homeostasis in epithelial
tissues (2).
Cystic fibrosis (CF) is caused by mutations that impair
synthesis and trafficking of the protein (3). The most common
lesion is deletion of the codon for Phe508 (ΔF508-CFTR). The
ΔF508-CFTRproteinismisfoldedandisrapidly degradedinthe
endoplasmic reticulum (4). The ΔF508 mutation inhibits folding
bydisruptinginteractions between NBD1
1 and intracellular loop
4 (ICL4) in the second transmembrane domain (TMD2) (5).
A treatment for CF would be to promote folding of ΔF508-
CFTR to increase the amount delivered to the cell surface
because ΔF508-CFTR retains some functional activity (6). An-
other goal would be to reduce the turnover of ΔF508-CFTR at
the cell surface as its half-life is 5-10-fold shorter than that of
wild-type protein (7).
Characterizationofsuppressormutationscouldprovideuseful
information needed to develop therapeutic strategies to repair
ΔF508-CFTR. The V510D suppressor mutation is interesting
because Val510 is predicted to reside at the domain-domain
interface between NBD1 and TMD2 in close proximity to
Phe508 (8). A negative charge appeared to be important because
the V510D mutation promoted maturation of ΔF508-CFTR
while mutation of Val510 to neutral amino acids (Cys, Gly, Ala,
Ser, Asn, Pro, Thr, Tyr) did not (9). In this study, we tested
whether the V510D mutation would reduce the turnover of
ΔF508-CFTR at the cell surface.
MATERIALS AND METHODS
Construction and Expression of Mutants. Mutations were
introduced into ΔF508-CFTR, ΔF508/ΔNBD2 (Δ1173-1480)-
CFTR, or ΔF508/ΔNBD2 (Δ1197-1480)-CFTR cDNAs con-
taining an A52 epitope tag at the C-terminal end (10)b ys i t e -
directed mutagenesis as described by Kunkel (11). The mutant
CFTRs were transiently expressed in HEK 293 cells as des-
cribed previously (5). HEK 293 cells were transfected with the
cDNAs, and the medium was changed 4 h later to fresh medium
(Dulbecco’s modified Eagle’s medium containing 10% (v/v)
calf serum). Cells were harvested 18-36 h after the change in
medium.Whole cellextractsof cells expressing untaggedorA52-
tagged CFTRs were subjected to immunoblot analysis using
6.5% (w/v) acrylamide gels and a CFTR polyclonal antibody or
monoclonal antibody A52. Generation of stable BHK cell lines
expressing wild-type or mutant ΔF508/V510D-CFTRs was
performed as described previously (9).
Disulfide Cross-Linking Analysis. HEK 293 cells were
transfected with W356C/W1145C-, ΔF508/W356C/W1145C-,
orΔF508/V510D/W356C/W1145C-CFTRcDNAs,andthecells
were incubated for 4 h at 37 C. The transfection medium was
removed, andthecells wereincubated infresh mediumovernight
at30C.Thecellswerethentreatedfor15minat20Cwith3μM
BMH. The medium was removed, and fresh medium containing
0.1 mM cysteine was added. Atvarious time pointsthe cells were
cooled on ice, harvested, and washed with PBS, and whole cell
SDS extracts were prepared. The reaction mixtures were then
subjected to SDS-PAGE (6.5% (w/v) polyacrylamide gels) and
immunoblot analysis with a rabbit polyclonal antibody against
CFTR (12). Intramolecular disulfide cross-linking between do-
mainsofCFTRcanbedetected becausethecross-linkedproduct
migrates with a slower mobility on SDS-PAGE gels (12). The
gel lanes were scanned and quantitated using the NIH Image
Program and an Apple computer.
Pulse-Chase and Cell Surface Labeling. Pulse-chase ex-
periments (13) or cell surface labeling with biotin-LC-hydrazide
†ThisworkwassupportedbyagrantfromtheCanadianInstitutesfor
HealthResearch(Grant62832).D.M.C.istherecipientoftheCanadian
Research Chair in Membrane Biology.
*Corresponding author. Tel/Fax: 416-978-1105. E-mail: david.
clarke@utoronto.ca.
1Abbreviations: TM, transmembrane; NBD, nucleotide-binding do-
main; HEK, human embryonic kidney; BHK, baby hamster kidney.Article Biochemistry, Vol. 49, No. 30, 2010 6353
after oxidation of carbohydrate with sodium periodate (14)w e r e
performed using HEK 293 cells transfected with A52-tagged
wild-type, ΔF508-, or ΔF508/V510D-CFTR cDNAs as de-
scribed previously. Pulse-chase assays were performed using
transfected HEK 293 cells maintained at 37 C. For cell surface
labeling, the medium was replaced 4 h after transfection, and the
cellsweregrownat 30 Cfor18h.Thecellswerebiotinylatedand
then grown in fresh media at 37 C for various intervals.
Iodide Efflux. Measurement of cAMP-stimulated iodide
efflux was performed on baby hamster kidney (BHK) cells
or BHK cells expressing wild-type or mutant ΔF508/V510D-
CFTRs as described previously (9, 15).
RESULTS
Effect of Charged Amino Acids at Position Val510 on
Maturation of ΔF508-CFTR. Models of CFTR structure
predict that the segment in NBD1 containing Phe508 to Val510
would lie close to the fourth intracellular loop (ICL4) in TMD2
that connects transmembrane segments 10 and 11 (Figure 1,
panels A and B). Recent crystal structures of wild-type NBD1
and ΔF508 NBD1 showed that deletion of Phe508 caused only
local structural changes in residues 509-511 such as increased
exposure of Val510 to solvent (16) (Figure 1, panels C and D). In
a modeling study, it was predicted that the negative charge of the
V510D mutation promoted maturation of ΔF508-CFTR be-
causeitrestoresdefectiveNBD1-TMD2interactionsbyforming
a salt bridge with Arg1070 (TMD2) (17). We tested this predic-
tion by introducing the charged amino acids Glu or Arg into
ΔF508-CFTR.HEK293cellsweretransfectedwiththecDNAof
wild-typeCFTR(Figure1E)ormutantsΔF508(Figure1,panels
E-H), V510D/ΔF508 (Figure 1F), V510E/ΔF508 (Figure 1G),
and V510R/ΔF508 (Figure 1H), and whole cell SDS extracts
were subjected to immunoblot analysis 18 h after transfection.
Mature and immature forms of CFTR can be distinguished in
SDS-PAGE gels because of differences in glycosylation. The
V510E mutation also promoted maturation, but it was less
efficient than the V510D mutation (12% and 35%, respectively)
(Figure 1, panels F and G). Little mature CFTR was observed
in mutant ΔF508 (Figure 1, panels E-H) or V510R/ΔF508
(Figure 1H).
It was possible that the high level of expression of V510D/
ΔF508 in the transiently transfected HEK 293 cells was also a
factor in enhancing maturation of the mutant. To examine the
extent of maturation at lower levels of expression, HEK 293 cells
weretransfectedwithlowerconcentrationsofplasmidcontaining
V510D/ΔF508 cDNA and whole cell extracts subjected to
immunoblot analysis 42 h after transfection. The time of incuba-
tion was increased so CFTR could be detected after transfection
with low cDNA concentrations. It was observed that expression
of CFTR was reduced when cells were transfected with lower
concentrationsofplasmid(Figure1I)buttherelativesteady-state
level of mature V510D/ΔF508-CFTR remained at about 50% of
total CFTR (Figure 1J).
Totestifthe mutantwasactive,BHKcelllines weregenerated
that stably expressed wild-typeor V510D/ΔF508-CFTRs for use
in iodide efflux assays. The relative expression level of mature to
total CFTR for mutant V510D/ΔF508 in BHK cells was also
found to be about 50% (data not shown). Iodide efflux assays
were performed rather than chloride channel measurements
because very few channels other than CFTR can conduct iodide
ions (18). Cells expressing wild-type or V510D/ΔF508-CFTRs
exhibited iodide efflux upon addition of forskolin (Figure 2).
Wild-type CFTR lacking NBD2 shows efficient matura-
tion (19). It was recently reported that rescue of ΔF508-CFTR
byothersuppressormutationsinNBD1(I539T,G550E,R553M,
R555K) was drastically reduced in wild-type CFTR lacking
NBD2 (ΔNBD2) (20). It was concluded that these suppressor
mutations likely promoted maturation through interactions with
NBD2 as well as other domains. We introduced the V510D
mutation into ΔF508-CFTR lacking NBD2 (truncated after
residue1196andcontainingtheepitopeformonoclonalantibody
A52 (Δ1197-1480)-A52) to test if it still promoted maturation.
Immunoblot analysis of whole cell SDS extracts (Figure 3, left
panel) showed that ΔF508/V510D/ΔNBD2-A52 (Δ1197-1480)
had a maturation efficiency (about 50%) that was similar to that
of the full-length ΔF508/V510D mutant (about 50%; Figure 1,
panel F).
FIGURE 1: Effect of charged amino acids at position Val510 at the
NBD1-TMD2 interface on maturation of ΔF508-CFTR. Amino
acids located at the NBD1-TMD2 (ICL4) interface in models of
CFTR (A (17); B (8)) that were mutated in this study are shown. The
crystal structure of NBD1 of wild-type (C) and ΔF508-CFTR (D)
(segment between Ile497 and Val520 is shown) shows that deletion of
Phe508exposesVal510tosolvent(16).WholecellextractsofHEK293
cells expressing full-length wild-type (E) or ΔF508-CFTRs (E-H) or
ΔF508-CFTRcontainingtheV510D(F),V510E(G),orV510Rmuta-
tion(H) weresubjectedtoimmunoblotanalysis18haftertransfection.
To test the maturation efficiency of ΔF508- and ΔF508/V510D-
CFTRs atvariouslevelsofexpression, HEK 293cells were transfected
with various levels of plasmid followed by immunoblot analysis and
enhanced chemiluminescence 42 h after transfection (I). The level of
mature CFTR relative to total CFTR in panel I was determined (J).
The positions of mature and immature CFTRs are indicated.6354 Biochemistry, Vol. 49, No. 30, 2010 Loo et al.
These results suggest that the V510D suppressor mutation
differs from other NBD1 suppressor mutations because the
absence of NBD2 did not reduce its effect. A potential problem
with this interpretation, however, is that the two studies used
different ΔF508/ΔNBD2 constructs. This study used a construct
truncated after residue 1196 (Δ1197-1480) whereas the other
study used a construct truncated after residue 1172 (Δ1173-
1480) (20). To test if the position of the truncation affected
maturation,mutantΔF508/V510D/ΔNBD2-A52(Δ1173-1480)
was constructed and expressed in HEK293 cells. Immunoblot
analysis of whole cell extracts showed that the V510D mutation
promoted maturation of the truncation mutant but the relative
level of mature was only about 20% of total CFTR protein.
It was predicted in a modeling study (17)t h a tt h eV 5 1 0 D
mutation may promote NBD1-TMD2 interactions in ΔF508-
CFTR by forming a salt bridge with positively charged residue
Arg1070 (TMD2). We tested the contribution of Arg1070 by
introducingtheR1070AchangeintoΔF508/V510D.Asshownin
Figure 4A, mature protein was not detectable in mutant ΔF508/
V510D/R1070A. To test if the R1070A mutation alone affected
maturation of ΔF508, mutants ΔF508/R1070A and ΔF508 were
expressed at 30 C. Maturation of both mutants was similar
(about 20%) (Figure 4B). Therefore, it was unlikely that the
R1070A mutant caused further misfolding of ΔF508-CFTR.
This is consistent with the observation that introduction of the
R1070A mutation into wild-type CFTR also did not affect its
maturation (data not shown).
Mutant ΔF508/V510R/R1070D was constructed to reverse
the positions of the charged residues. Figure 4C shows that the
V510R/R1070D mutations promoted maturation of ΔF508-
CFTR. Both mutations were required because the presence of
V510R (Figure 1H) or R1070D (Figure 4D) alone did not
promote maturation of ΔF508-CFTR. These results suggest that
V510D may form a salt bridge with Arg1070 in ΔF508-CFTR.
The ΔF508 mutation reduces the stability of CFTR at the cell
surface (7). To test if the V510D mutation increased the stability
of ΔF508-CFTR, a cross-linking assay was used to measure the
half-life of mature CFTR at the cell surface. We previously
showed that cysteines introduced into TM segments 6 (W356C)
and 12 (W1145C) could be cross-linked in mature CFTR when
whole cells were treated with bifunctional thiol cross-lin-
kers (14, 15). Cross-linked mature CFTR was readily detected
because it migrates with a slower mobility on SDS-PAGE gels.
Cross-linking of immature CFTR was not detected. Therefore,
thecross-linkingcanbeusedasareportertomonitor turnover of
mature CFTR at the cell surface. Accordingly, the W356C and
W1145C mutations were introduced into wild-type, ΔF508-, and
ΔF508/V510D-CFTRs.Transfectedcellswereincubatedfor24h
at 30 C and then treated with 3 μM 1,6-bismaleimidohexane
(BMH) for 15 min at 21 C. BMH was used instead of the
bifunctional methanethiosulfonate cross-linkers (14) because
maleimide-type cross-links are not reduced by thiol-reducing
compounds such as dithiothreitol. BMH was then removed, and
fresh medium containing 0.1 mM cysteine was added. Cells were
harvestedatvarious intervalsandwhole cellextractssubjected to
immunoblot analysis. Panels A and B of Figure 5 show that the
half-lives of cross-linked wild-type/W356C/W1145C-, ΔF508/
W356C/W1145C-, and ΔF508/V510D/W356C/W1145C-CFTRs
wereabout12,3,and14h,respectively.Theseresultsindicatethat
the stability of mutant V510D/ΔF508-CFTR resembled that of
wild-type protein.
A potential problem with the cross-linking assay is that it
requiredintroductionofapairofcysteinesintotheTMsegments
of CFTR. It was possible that cysteines W356C and W1145C
mayinfluencethestabilityoftheprotein.Toexaminetheeffectof
the V510D mutation on turnover of ΔF508-CFTR without the
introduced cysteines, a pulse-chase assay was performed. It was
observed that the rate of conversion of immature wild-type
CFTR to the mature form was nearly complete by 2-4h
(Figure 6A, top panel). By contrast, the conversion of immature
to mature form in mutant ΔF508/V510D was slower since there
wasconsiderableamountofimmatureCFTRstillpresentat2-4h
(Figure 6A, bottom panel). No mature protein was detected in
mutant ΔF508-CFTR because there is little maturation when
expression is performed at 37 C (Figure 6A, middle panel).
After an 8 h chase, the majority of labeled CFTR in wild-type
and mutant ΔF508/V510D was present as the mature protein
FIGURE 2: Iodide efflux activity of wild-type and ΔF508/V510D-
CFTR. Iodide efflux assays were performed on BHK cells stably
expressing wild-type CFTR, mutant ΔF508/V510D, or no CFTR
(control). At time 0, forskolin was added to start stimulation of the
iodide-loaded cells. Each value is the mean ( SD (n = 9).
FIGURE 3: Effect of V510D on maturation of ΔF508/ΔNBD2 mu-
tants. Immunoblots of HEK 293 cells expressing A52-tagged CFTR
mutants lacking NBD2 that were truncated after residue 1196
(Δ1197-1480) or 1172 (Δ1173-1480). The positions of mature and
immature ΔNBD2-CFTRs are indicated.
FIGURE 4: EffectofArg1070andVal510mutationsonmaturationof
ΔF508-CFTR. Whole cell immunoblots were performed on HEK
293 cells that were transfected with the indicated ΔF508-CFTR
mutants and incubated for 18 h at 37 C (A, C, D) or 30 C (B).
The positions of mature and immature CFTRs are indicated.Article Biochemistry, Vol. 49, No. 30, 2010 6355
(Figure 6A). Therefore, we used this time point to compare the
lifetimes of the mature protein in wild-type and mutant ΔF508/
V510D. Figure 6 (panels B and C) shows that the half-lives of
both proteins were similar (12-14 h). The results indicate that
V510D stabilizes ΔF508-CFTR.
To test if V510D stabilizes ΔF508-CFTR at the cell surface,
cells expressing wild-type, ΔF508-, or ΔF508/V510D-CFTRs
werefirstincubatedat30Cfor18hsothatΔF508-CFTRwould
be present at the cell surface. CFTR at the cell surface was then
biotinylated. The cells were washed to remove biotin-LC-hydra-
zide,andcellswereharvestedatvarioustimepointsafterlabeling.
LabeledCFTRwasimmunoprecipitated,samplesweresubjected
to SDS-PAGE, and CFTR was detected with streptavidin
conjugated to horseradish peroxidase. It was found that mature
forms of wild-type or ΔF508/V510D-CFTRs had similar half-
lives of about 12 h while ΔF508-CFTR had a short half-life
of about 2 h (Figure 7).
DISCUSSION
The folding and trafficking defects of ΔF508-CFTR can be
partially overcome by expressing the mutant at lower tempera-
turestoyieldapartiallyfunctionalmoleculeatthecellsurface(6).
The mutant is unstable at the cell surface, however, because it
shows a 5-10-fold shorter half-life than wild-type protein when
cells are returned to 37 C( 21). This study showed that the
V510D mutation increased the cell surface stability of mature
ΔF508-CFTR to levels that were similar to the wild-type protein
(Figures 5-7).
A similar effect was observed when the combination of four
NBD1suppressormutations(I539T,G550E,R553M,R555K) was
introduced into ΔF508-CFTR (20). Mature wild-type CFTR and
mature ΔF508-CFTR containing the four suppressor mutations
FIGURE 5: Measurement of cell surface stability by cross-linking
assay. HEK 293 cells expressing wild-type, ΔF508-, or ΔF508/
V510D-CFTRs containing the W356C and W1145C cysteines were
treated with the thiol cross-linker BMH. The cross-linker was then
removed at time 0, and whole cell extracts were subjected to im-
munoblot analysis at the indicated times (A), and the level of cross-
linked CFTR remaining at each time point was quantitated (B). The
positions of immature, mature, and cross-linked (X-link) forms of
CFTR are indicated.
FIGURE 6: Metabolic labeling of CFTR. HEK 293 cells were trans-
fectedwithA52-taggedwild-type,ΔF508,orΔF508/V510DcDNAs.
After 24 h, the cells were pulse-labeled with [
35S]-L-methionine and
[
35S]-L-cystine for 30 min at 37 C. Cells were chased and samples
collectedimmediately(time0h)andatvariousintervals(A).Time0h
in (B) is 8 h after chase. At each time point cells were solubilized and
labeled CFTR immunoprecipitated with monoclonal antibody A52.
The immunoprecipitates were subjected to SDS-PAGE and fluoro-
graphy. The amount of mature labeled CFTR at each time point (B)
wasquantitatedandexpressedrelativetotime0(C).Thepositionsof
mature and immature CFTRs are indicated.
FIGURE 7: Cell surface labeling of CFTR. HEK 293 cells were
transfected with the cDNAs of A52-tagged wild-type, ΔF508-, or
ΔF508/V510D-CFTR. To compare the half-life of ΔF508-CFTR to
wild-type or mutant ΔF508/V510D-CFTR, the cells were first in-
cubated at 30 C to promote maturation and increase the level of
ΔF508-CFTR at the cell surface. After 18 h at 30 C, cells were
biotinylated. The biotin-LC-hydrazide was removed and replaced
with fresh media. The cells were then harvested immediately (time 0)
andattheindicatedtimepoints.Thecellsweresolubilizedandlabeled
CFTR collected by immunoprecipitation with monoclonal anti-
body A52. The samples were subjected to SDS-PAGE and CFTR
detected with streptavidin conjugated to horseradish peroxidase
followed by enhanced chemiluminescence. The position of mature
CFTR is indicated.6356 Biochemistry, Vol. 49, No. 30, 2010 Loo et al.
had half-lives of about 12 h. Although the effects of these
suppressor mutations on full-length CFTR were similar to
that of V510D, there were different effects on NBD2 deletion
mutants. This suggested that the mutations might be affect-
ing different domain-domain interactions. The V510D muta-
tion (present study) appeared to restore stability by promoting
NBD1-TMD2 interactions in ΔF508-CFTR since deletion of
NBD2 had little effect (Figure 3; Δ1197-1480). By contrast,
He et al. (20) concluded that the NBD1 suppressor mutations
enhanced maturation by promoting NBD1-NBD2 interac-
tions because the effects were greatly diminished when NBD2
was absent. These differences in the two studies could be due
to different NBD2 mutants used. Maturation of CFTR in
C-terminal deletion mutants is sensitive to the location of the
truncation (22). Therefore, mutant ΔF508/ΔNBD2 (Δ1173-
1480) might have been more difficult to rescue compared to
full-length ΔF508-CFTR as it was less sensitive to reduced tem-
perature (20). In contrast, maturation of the ΔF508/ΔNBD2
usedinthisstudy(Δ1197-1480) wassimilartothatoffull-length
ΔF508-CFTR at 30 C (data not shown). Other evidence
suggesting that ΔF508/ΔNBD2 (Δ1173-1480) was more diffi-
cult to rescue was the observation that introduction of V510D
into the mutant yielded lower levels of mature protein com-
pared to the ΔF508/ΔNBD2/V510D (Δ1197-1480) construct
(Figure 3).
Mutational analysis of Arg1070 in TMD2 yielded evidence
that was consistent with the prediction that an aspartic acid
introduced into position Val510 may stabilize ΔF508-CFTR
through interactions with Arg1070. Mutation of Arg1070 to a
neutral amino acid abolished V510D rescue of ΔF508-CFTR
while V510R only rescued the mutant when the R1070D
change was introduced (Figure 4C). The pattern of effects of
theVal510andArg1070 mutations wassimilar to thatreported
for residues that were predicted to form a salt bridge bet-
ween TM segments 6 (Arg347) and 8 (Asp924) in wild-type
CFTR (23). It was found that mutation of Arg347 to neutral
amino acids or Asp destabilized channel function but the
D924R mutation complemented R347D to yield a channel
that behaved like wild-type CFTR. The authors concluded that
a salt bridge between Arg347 and Asp924 plays an important
structural role in CFTR.
Comparison of the initial crystal structures of wild-type and
ΔF508 NBD1s from CFTR suggested that the deletion only
caused local structural changes restricted to residues 509-
511 (24, 25). A potential problem with these initial structures,
however, was that additional mutations had to be introduced to
enhance the solubility of the proteins. The solubility-enhancing
mutations may have altered the structure of ΔF508-NBD1.
A recent study addressed the concerns about the impact of
the solubility-enhancing mutations by examining NBD1 crystal
structures that had fewer and different solubilizing muta-
tions (16). It was found that the only consistent conformational
changes occurred at residues 509-511. Residue Val510 was
buried in all non-ΔF508 structures but completely solvent
exposed in all ΔF508 structures. Mass spectroscopy measure-
ments also showed that the ΔF508 mutation increased backbone
dynamics at residues 509-511. It was suggested that increased
exposure and dynamics of the 509-511 loop could promote
aberrant intermolecular interactions that impede traffick-
ing in vivo. Residue Val510 was predicted to be particularly
important because increased exposure of its hydrophobic side
chain to solvent could promote local unfolding and chaperone
interactions leading to retention in the endoplasmic reticulum.
Second-site suppressor mutations at Val510 to less hydrophobic
residues such as aspartic acid may reverse the alteration in
the local structure of the protein caused by the ΔF508 mutation
or prevent intermolecular interactions that lead to retention in
the endoplasmic reticulum or increased turnover at the cell
surface. It is also possible that changes to Val510 may have
multiple effects because we observed that various mutations
had different effects in promoting maturation of Cys-less or
Δ508-CFTR (see below).
In this study we found that the ΔF508/V510D mutant was
active while we failed to detect activity when V510D was
introduced into Cys-less CFTR (9). Although Cys-less/V510D-
CFTR matured,its chloride channel activitywas belowthelimits
ofdetectionintheiodideeffluxassay.Anexplanationmaybedue
to structural differences between Cys-less and ΔF508-CFTRs.
Cys-less CFTR was constructed by mutating the 18 endogenous
cysteines to alanine or leucine. Mutation of all the cysteines
yieldedamutantthatalsofailedtomature.Whileintroductionof
V510D into Cys-less or ΔF508-CFTRs promoted maturation,
the Cys-less mutant was different because its maturation could
also be promoted by changing Val510 to Thr, Cys, Gly, Ala, or
Ser.Therefore,thestructuraldifferencesinthe508-511regionof
Cys-lessCFTRmayexplainwhy theV501D/Cys-lessmutantdid
not show iodide efflux activity (9).
In summary, the V510D mutation increases the stability
of ΔF508-CFTR by promoting NBD1-TMD2 interactions
likely through formation of a salt bridge with Arg1070 in
ICL4. A potential therapeutic strategy would be to mimic these
effects using a compound that directly binds to the protein
(pharmacological chaperone).
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